Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patients.
Zoref-Lorenz A, Murakami J, Gurion R, Iyer SP, Abadi U, Cohen I, Goyal G, Mohamed SF, Nikiforow S, Natour AEH, Weinstein S, Yacobovich J, Cho HL, Raanani P, Nagler A, Berliner N, Daver NG, Itchaki G, Izraeli S, Ellis M, Jordan MB. Zoref-Lorenz A, et al. Among authors: ellis m. Blood Adv. 2025 Apr 18:bloodadvances.2024014005. doi: 10.1182/bloodadvances.2024014005. Online ahead of print. Blood Adv. 2025. PMID: 40249910
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.
Mittelman M, Filanovsky K, Ofran Y, Rosenbaum H, Raanani P, Braester A, Goldschmidt N, Kirgner I, Herishanu Y, Perri C, Ellis M, Oster HS; Israel Myelodysplastic Syndrome Working Group (MDS-WG). Mittelman M, et al. Among authors: ellis m. Ann Hematol. 2016 Oct;95(11):1811-8. doi: 10.1007/s00277-016-2776-x. Epub 2016 Aug 22. Ann Hematol. 2016. PMID: 27546027 Clinical Trial.
Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.
Leader A, Benyamini N, Gafter-Gvili A, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, De Geest S, Raanani P. Leader A, et al. Among authors: ellis m. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e449-e461. doi: 10.1016/j.clml.2018.06.026. Epub 2018 Jun 25. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30030034
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T. Levy I, et al. Among authors: ellis m. Leuk Lymphoma. 2021 Dec;62(14):3384-3393. doi: 10.1080/10428194.2021.1966782. Epub 2021 Aug 18. Leuk Lymphoma. 2021. PMID: 34405767
2,432 results